跳至主要内容
临床试验/TCTR20141027001
TCTR20141027001已完成未知

A single-blind randomized controlled trial of AVS023 poly-herbal formula for Acute low back pain: a pilot study

Faculty of Medicine Siriraj Hospital0 个研究点目标入组 29 人开始时间: 2014年10月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
29

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1.Men and women aged 18–65 years, who diagnosed with nonspecific acute LBP.
  • 2.The eligible patients had moderate to severe acute LBP at baseline (score ≥ 4 on an 11-point numerical rating scale [NRS]; 0 = no pain,” 10 = pain as very bad as patient can imagine”) for less than 72 hours.
  • 3.Participants were informed by written consent.

排除标准

  • 1.Patients who had a history of lumbar and spinal accident in former 1 year or lumbosacral surgery.
  • 2.Patients who had a history of osteoporosis, immunodeficiency, diabetes mellitus, hypertension, cardiovascular disease, thyroid, endocrine gland disease and asthma.
  • 3.Patients who have a current active peptic-duodenal ulcer, gastro-esophageal reflux disease (GERD).
  • 4.Patients who had a history of epilepsy or recurrent seizures; have current active liver disease (abnormal liver function test or aspartate aminotransferase (AST) and alanine aminotransferase (ALT) elevated more than 2 times of upper normal limit).
  • 5.Patients who had creatinine clearance (CrCl) less than 50 ml/min or any significant renal disease.
  • 6.Patients who have blood pressure over 140/90 mmHg; known hypersensitivity to Ibuprofen or AVS023 or herbal and pollen grain.
  • 7.Patients who concomitant use of phenytoin, rifampicin, propranolol, theophylline, corticosteroids, other anti-inflammatory, anticoagulant and antiplatelet in a current medication.
  • 8.Pregnancy or lactating.
  • 9.Patients who required treatment with an opioid analgesic.
  • 10.Patients who prior either drugs NSAIDs, AVS023 or any analgesics, anti-inflammatory and muscle relaxants treatment within 1 week.

研究者

相似试验